Dr. Ron Tomer (53) was born and raised in Tel Aviv. He received his bachelor’s degree in Pharmacy in 1991 from the School of Pharmacy at the Hebrew University of Jerusalem. He then went on to pursue his PhD research at the School of Pharmacy at the University of London, which he completed in 1994. Dr. Tomer also holds an MBA from the Recanati School of Business at the Tel Aviv University.
Son of Zvulun Tomer (83), founder of Unipharm Ltd., a leading Israeli generic pharmaceutical company, Ron joined his parents in the family business in 1995. Since then, Ron has contributed to Unipharm’s growth significantly, transforming it from a small company to one of Israel’s largest generic pharmaceutical companies and a drug supplier to hundreds of thousands of Israeli citizens. Granting affordable access to medicines by developing and producing generic pharmaceuticals has always been a cornerstone of Unipharm’s vision. In 2017 Unipharm opened its new EU-GMP compliant state-of-the-art manufacturing facility in Mavo Carmel, Israel. This facility is built with the newest technologies in pharma manufacturing, allowing increased production efficiency and cost savings. Unipharm Mavo Carmel is now starting to export its many generic products to Europe, while expanding to additional International Markets.
On January 30th 2020, Dr. Ron Tomer was elected President of Manufacturers Association of Israel. 788 manufacturers participated in the election, the highest number of participants in elections of the association ever. Prior to that, Dr. Tomer served as the Manufacturers’ Association of Israel (MAI)’s Chairman of Communications committee, Chairman of the “Made in Israel” committee during 2009 to 2016, advocating for Israeli locally produced goods. He is an active Presidential Board Member of MAI, and during 2017-2019 he served as the Chairman of the Committee of Economy and Regulation at MAI, routinely working with the Minister of Economy, the Minister of Finance, and the Bank of Israel. During his leadership period, a regulatory roadmap for the Israeli Manufacturers was created in collaboration between MAI, Governmental Offices, and the Israel Democracy Institute, paving the way for a significant decrease in the regulatory burden on Israeli Manufacturers.
Dr. Tomer also served as a member of the Professional Committee of the Pharmaceutical Industry Branch in the Manufacturers Association, driving significant advancements in the Israeli Pharmaceutical Industry. He is an active Board Member of the Pharmacy Society of Israel and is the Head of the Pharmacy Society’s Professional Committee.
Dr. Ron Tomer is an expert in the field of pharmaceutical patents and actively pursues patent challenges that welcome the generic drug competition into the market.
Ron is active on the Board of Trustees of the House of Wheels for handicapped children and on the Steering Committee of Nitzan Horim, the Branch of the Israeli Association for Children and Adults with Learning Disabilities that focuses on learning-disabled parents by guiding them through their parenting lives.
Ron is married to Esti, and the two raise three daughters in Tel Aviv.